Melanotan II 10mg vial

Melanocortin

What is Melanotan II?

Last updated: 29 October 2026

A synthetic cyclic peptide that acts as a non-selective melanocortin receptor agonist.

Melanocortin agonistResearch compound · not approved
Class
Non-selective melanocortin agonist
Also known as
MT-II
Type
Cyclic heptapeptide
Research stage
Research compound; not approved

01 · Classification

What it is

Melanotan II is a cyclic, lactam-bridged analogue of alpha-MSH, developed at the University of Arizona. Cyclisation makes it far more stable and potent than the native hormone in study models.

It activates several melanocortin receptors, which is why it is used in research mapping the roles of each receptor subtype.

02 · Mechanisms

What has been studied

  • MC1R: the receptor that controls melanin production in melanocytes.
  • MC3R and MC4R: central receptors studied in energy-balance signalling.
  • Non-selectivity: because it hits several subtypes, it is often compared with more selective analogues.

03 · Evidence

Where the research is

Not approved by the FDA for any use. The FDA has issued public warnings about unapproved products sold for human use.

04 · Primary sources

Read the literature

Search the primary research record directly rather than relying on summaries, including this one.

Research use only

Supplied strictly for laboratory and educational research. Not a drug, not for human or veterinary use, and not evaluated by the FDA. This overview is not medical advice and gives no dosing or administration guidance.

← All research overviews